Mini Symposium
Markolf Hanefeld (Germany)
Opening remarks
Hugh Jones (UK)
Beneficial effects of Testosterone Therapy on Obesity, CV Risk and Mortality in Type 2 Diabetes
Sandeep Dhindsa (USA)
Testosterone Therapy for Treatment of Type 2 Diabetes
Lars Rydén (Sweden)
Closing remarks